U.S. Physical Therapy, Inc.
USPH
$73.85
-$0.09-0.12%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 17.85% | 17.06% | 16.42% | 14.12% | 9.31% |
| Total Other Revenue | 14.61% | 23.19% | 27.00% | 30.14% | 26.90% |
| Total Revenue | 17.28% | 18.05% | 18.11% | 16.56% | 12.01% |
| Cost of Revenue | 17.86% | 16.77% | 19.29% | 18.78% | 7.52% |
| Gross Profit | 15.26% | 22.24% | 13.68% | 11.29% | 31.34% |
| SG&A Expenses | 21.06% | 22.65% | 15.34% | 12.01% | 19.40% |
| Depreciation & Amortization | 32.15% | 33.54% | 42.60% | 19.34% | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.57% | 17.85% | 19.54% | 18.15% | 11.74% |
| Operating Income | 6.81% | 19.55% | 4.29% | 3.45% | 14.26% |
| Income Before Tax | 85.43% | 53.11% | 17.43% | 17,184.91% | -21.82% |
| Income Tax Expenses | 104.49% | 60.01% | 22.97% | 316.58% | -28.06% |
| Earnings from Continuing Operations | 80.44% | 51.30% | 15.93% | 1,066.28% | -20.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -43.03% | -26.65% | 0.06% | -266.75% | -6.10% |
| Net Income | 98.22% | 65.11% | 23.03% | 1,309.15% | -28.38% |
| EBIT | 6.81% | 19.55% | 4.29% | 3.45% | 14.26% |
| EBITDA | 11.89% | 22.22% | 12.90% | 10.34% | 13.52% |
| EPS Basic | 23.61% | 24.12% | 71.58% | 236.93% | -23.85% |
| Normalized Basic EPS | -23.40% | 4.27% | -16.96% | -52.84% | 15.46% |
| EPS Diluted | 23.61% | 24.12% | 71.58% | 236.93% | -23.85% |
| Normalized Diluted EPS | -23.40% | 4.27% | -16.96% | -52.84% | 15.46% |
| Average Basic Shares Outstanding | 0.84% | 0.83% | 0.77% | 0.68% | 0.60% |
| Average Diluted Shares Outstanding | 0.84% | 0.83% | 0.77% | 0.68% | 0.60% |
| Dividend Per Share | 2.27% | 2.27% | 2.27% | 2.33% | 2.33% |
| Payout Ratio | -0.48% | -0.38% | -- | -0.93% | 0.44% |